Cargando…
Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle
As virtual reality (VR) has drastically evolved over the past few years, the field of applications of VR flourished way beyond the gaming industry. While commercial VR solutions might be available, there is a need to develop a workflow for specific applications. Bioprinting represents such an exampl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218671/ https://www.ncbi.nlm.nih.gov/pubmed/35757809 http://dx.doi.org/10.3389/fbioe.2022.895842 |
_version_ | 1784731941138857984 |
---|---|
author | Gretzinger, Sarah Schmieg, Barbara Guthausen, Gisela Hubbuch, Jürgen |
author_facet | Gretzinger, Sarah Schmieg, Barbara Guthausen, Gisela Hubbuch, Jürgen |
author_sort | Gretzinger, Sarah |
collection | PubMed |
description | As virtual reality (VR) has drastically evolved over the past few years, the field of applications of VR flourished way beyond the gaming industry. While commercial VR solutions might be available, there is a need to develop a workflow for specific applications. Bioprinting represents such an example. Here, complex 3D data is generated and needs to be visualized in the context of quality control. We demonstrate that the transfer to a commercially available VR software is possible by introducing an optimized workflow. In the present work, we developed a workflow for the visualization of the critical quality attribute (cQA) cell distribution in bioprinted (extrusion-based) samples in VR. The cQA cell distribution is directly influenced by the pre-processing step mixing of cell material in the bioink. Magnetic Resonance Imaging (MRI) was used as an analytical tool to generate spatially resolved 2.5 and 3D data of the bioprinted objects. A sample with poor quality in respect of the cQA cell distribution was identified as its inhomogeneous cell distribution could be displayed spatially resolved in VR. The described workflow facilitates the usage of VR as a tool for quality inspection in the field of bioprinting and represents a powerful tool for visualization of complex 3D MRI data. |
format | Online Article Text |
id | pubmed-9218671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92186712022-06-24 Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle Gretzinger, Sarah Schmieg, Barbara Guthausen, Gisela Hubbuch, Jürgen Front Bioeng Biotechnol Bioengineering and Biotechnology As virtual reality (VR) has drastically evolved over the past few years, the field of applications of VR flourished way beyond the gaming industry. While commercial VR solutions might be available, there is a need to develop a workflow for specific applications. Bioprinting represents such an example. Here, complex 3D data is generated and needs to be visualized in the context of quality control. We demonstrate that the transfer to a commercially available VR software is possible by introducing an optimized workflow. In the present work, we developed a workflow for the visualization of the critical quality attribute (cQA) cell distribution in bioprinted (extrusion-based) samples in VR. The cQA cell distribution is directly influenced by the pre-processing step mixing of cell material in the bioink. Magnetic Resonance Imaging (MRI) was used as an analytical tool to generate spatially resolved 2.5 and 3D data of the bioprinted objects. A sample with poor quality in respect of the cQA cell distribution was identified as its inhomogeneous cell distribution could be displayed spatially resolved in VR. The described workflow facilitates the usage of VR as a tool for quality inspection in the field of bioprinting and represents a powerful tool for visualization of complex 3D MRI data. Frontiers Media S.A. 2022-06-09 /pmc/articles/PMC9218671/ /pubmed/35757809 http://dx.doi.org/10.3389/fbioe.2022.895842 Text en Copyright © 2022 Gretzinger, Schmieg, Guthausen and Hubbuch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Gretzinger, Sarah Schmieg, Barbara Guthausen, Gisela Hubbuch, Jürgen Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title | Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title_full | Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title_fullStr | Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title_full_unstemmed | Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title_short | Virtual Reality as Tool for Bioprinting Quality Inspection: A Proof of Principle |
title_sort | virtual reality as tool for bioprinting quality inspection: a proof of principle |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218671/ https://www.ncbi.nlm.nih.gov/pubmed/35757809 http://dx.doi.org/10.3389/fbioe.2022.895842 |
work_keys_str_mv | AT gretzingersarah virtualrealityastoolforbioprintingqualityinspectionaproofofprinciple AT schmiegbarbara virtualrealityastoolforbioprintingqualityinspectionaproofofprinciple AT guthausengisela virtualrealityastoolforbioprintingqualityinspectionaproofofprinciple AT hubbuchjurgen virtualrealityastoolforbioprintingqualityinspectionaproofofprinciple |